TWO SIGMA ADVISERS, LP - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$26,000
+44.4%
432,216
+304.3%
0.00%
Q2 2022$18,000
-48.6%
106,916
+17.4%
0.00%
Q2 2019$35,000
-35.2%
91,100
-4.4%
0.00%
Q1 2019$54,000
+42.1%
95,300
+0.2%
0.00%
Q4 2018$38,000
-11.6%
95,100
+11.2%
0.00%
Q3 2018$43,000
-77.0%
85,500
+0.8%
0.00%
-100.0%
Q2 2018$187,000
+28.1%
84,800
+98.1%
0.00%
Q1 2018$146,000
+484.0%
42,800
+307.6%
0.00%
Q2 2015$25,00010,5000.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders